EA200300420A1 - Выделенная молекула нуклеиновой кислоты, выделенный полипептид и способ его получения, способ обнаружения их присутствия в образце (варианты), клетка-хозяин (варианты), антитело, набор (варианты), способ модулирования активности полипептида, способ идентификации (варианты) и применение соединения, способ выявления субъекта (варианты) и способ лечения субъекта с нарушением, связанным с калиевыми каналами (варианты) - Google Patents
Выделенная молекула нуклеиновой кислоты, выделенный полипептид и способ его получения, способ обнаружения их присутствия в образце (варианты), клетка-хозяин (варианты), антитело, набор (варианты), способ модулирования активности полипептида, способ идентификации (варианты) и применение соединения, способ выявления субъекта (варианты) и способ лечения субъекта с нарушением, связанным с калиевыми каналами (варианты)Info
- Publication number
- EA200300420A1 EA200300420A1 EA200300420A EA200300420A EA200300420A1 EA 200300420 A1 EA200300420 A1 EA 200300420A1 EA 200300420 A EA200300420 A EA 200300420A EA 200300420 A EA200300420 A EA 200300420A EA 200300420 A1 EA200300420 A1 EA 200300420A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- options
- variants
- subject
- identification
- nucleic acid
- Prior art date
Links
- 102000039446 nucleic acids Human genes 0.000 title abstract 5
- 108020004707 nucleic acids Proteins 0.000 title abstract 5
- 150000007523 nucleic acids Chemical class 0.000 title abstract 5
- 102000004257 Potassium Channel Human genes 0.000 title abstract 3
- 108020001213 potassium channel Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 230000000694 effects Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 5
- 229920001184 polypeptide Polymers 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 101100025911 Mus musculus Ncoa3 gene Proteins 0.000 abstract 5
- 239000013604 expression vector Substances 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/670,756 US7078481B1 (en) | 1998-11-20 | 2000-09-27 | Potassium channel interactors and uses therefor |
US09/703,094 US7556938B1 (en) | 1998-11-20 | 2000-10-31 | Nucleic acids encoding potassium channel interactors |
PCT/US2001/030463 WO2002026984A2 (en) | 2000-09-27 | 2001-09-27 | Potassium channel interactors and uses therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200300420A1 true EA200300420A1 (ru) | 2004-04-29 |
Family
ID=27100393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200300420A EA200300420A1 (ru) | 2000-09-27 | 2001-09-27 | Выделенная молекула нуклеиновой кислоты, выделенный полипептид и способ его получения, способ обнаружения их присутствия в образце (варианты), клетка-хозяин (варианты), антитело, набор (варианты), способ модулирования активности полипептида, способ идентификации (варианты) и применение соединения, способ выявления субъекта (варианты) и способ лечения субъекта с нарушением, связанным с калиевыми каналами (варианты) |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1322759A2 (xx) |
JP (1) | JP2004525610A (xx) |
KR (1) | KR20030074604A (xx) |
CN (1) | CN1498271A (xx) |
AU (1) | AU2001296393A1 (xx) |
BR (1) | BR0114383A (xx) |
CA (1) | CA2420960A1 (xx) |
CZ (1) | CZ20031154A3 (xx) |
EA (1) | EA200300420A1 (xx) |
IL (1) | IL154962A0 (xx) |
MX (1) | MXPA03002557A (xx) |
NO (1) | NO20031369L (xx) |
WO (1) | WO2002026984A2 (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7067312B1 (en) | 2001-09-19 | 2006-06-27 | Myriad Genetics, Inc. | PN7718 nucleic acids and use thereof |
EP1572102A4 (en) * | 2002-11-01 | 2006-06-14 | Decode Genetics Ehf | HUMAN DIABETES TYPE II: PATHWAY OF THE KV-PROTEIN INTERACTION GENE (KCHIP1) LOCATED ON CHROMOSOME 5 |
US9029080B2 (en) * | 2008-11-06 | 2015-05-12 | Basf Se | Screening assay for insecticides |
CN105483276B (zh) * | 2016-02-01 | 2019-06-11 | 成都望路医药技术有限公司 | Kcnip4基因及其表达产物在直肠腺癌诊疗中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4758997A (en) * | 1996-10-17 | 1998-05-11 | Nps Pharmaceuticals, Inc. | Potassium channel blocking compounds and their use |
US6117989A (en) * | 1998-03-26 | 2000-09-12 | Incyte Pharmaceuticals, Inc. | Human calcium-binding proteins |
JP2002530104A (ja) * | 1998-11-20 | 2002-09-17 | ミレニアム ファーマスーティカルズ インク | カリウムチャンネル相互作用物質及びその利用法 |
AU5151100A (en) * | 1999-05-19 | 2000-12-05 | Incyte Genomics, Inc. | Extracellular signaling molecules |
EP1242443A4 (en) * | 1999-12-23 | 2005-06-22 | Nuvelo Inc | NEW NUCLEIC ACIDS AND POLYPEPTIDES |
-
2001
- 2001-09-27 CN CNA018191681A patent/CN1498271A/zh active Pending
- 2001-09-27 JP JP2002530747A patent/JP2004525610A/ja active Pending
- 2001-09-27 CZ CZ20031154A patent/CZ20031154A3/cs unknown
- 2001-09-27 KR KR10-2003-7004460A patent/KR20030074604A/ko not_active Application Discontinuation
- 2001-09-27 IL IL15496201A patent/IL154962A0/xx unknown
- 2001-09-27 CA CA002420960A patent/CA2420960A1/en not_active Abandoned
- 2001-09-27 WO PCT/US2001/030463 patent/WO2002026984A2/en not_active Application Discontinuation
- 2001-09-27 AU AU2001296393A patent/AU2001296393A1/en not_active Abandoned
- 2001-09-27 BR BR0114383-2A patent/BR0114383A/pt not_active IP Right Cessation
- 2001-09-27 MX MXPA03002557A patent/MXPA03002557A/es unknown
- 2001-09-27 EP EP01977260A patent/EP1322759A2/en not_active Withdrawn
- 2001-09-27 EA EA200300420A patent/EA200300420A1/ru unknown
-
2003
- 2003-03-26 NO NO20031369A patent/NO20031369L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002026984A2 (en) | 2002-04-04 |
CZ20031154A3 (cs) | 2003-09-17 |
WO2002026984A3 (en) | 2003-03-13 |
CN1498271A (zh) | 2004-05-19 |
NO20031369D0 (no) | 2003-03-26 |
IL154962A0 (en) | 2003-10-31 |
KR20030074604A (ko) | 2003-09-19 |
NO20031369L (no) | 2003-05-22 |
EP1322759A2 (en) | 2003-07-02 |
BR0114383A (pt) | 2005-04-12 |
CA2420960A1 (en) | 2002-04-04 |
JP2004525610A (ja) | 2004-08-26 |
AU2001296393A1 (en) | 2002-04-08 |
MXPA03002557A (es) | 2004-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR19C1020I1 (fr) | Nouvelles molecules b7-4 et leurs utilisations | |
CA2413857A1 (en) | Pd-l2 molecules: pd-1 ligands and uses therefor | |
WO1999066025A3 (en) | Mtbx protein and nucleic acid molecules and uses therefor | |
CY1107629T1 (el) | Πρωτεïνη crsp (πλουσιες σε κυστεïνη εκκρινομενες πρωτεïνες) μορια νουκλεϊνικου οξεως που τις κωδικοποιουν και χρησεις τους | |
ATE366814T1 (de) | Gl50 moleküle, sowie verwendungen derselben | |
ATE419358T1 (de) | Gebrauchsverfaheren eines neuen lysyloxidase- verwandten proteins | |
WO1999043808A8 (en) | Human c-maf compositions and methods of use thereof | |
EP1009752A4 (en) | NOVEL TANGO-77 PROTEIN FAMILY MOLECULES AND USES THEREOF | |
DE60144021D1 (de) | Für zellzyklusproteine kodierende nukleinsäure und deren verwendung | |
BR0109524A (pt) | Molécula de ácido nucleico isolada, vetor, célula hospedeira, método para produzir um polipeptìdeo, polipeptìdeo isolado, anticorpo, método para detectar a presença de um polipeptìdeo em uma amostra, kit, e, métodos para detectar a presença de uma molécula de ácido nucleico em uma amostra, para identificar um composto e para modular a atividade de um polipeptìdeo | |
WO1998011238A3 (en) | Protease m, a novel serine protease | |
WO2002103015A3 (en) | Abca10 transporter | |
EA200300420A1 (ru) | Выделенная молекула нуклеиновой кислоты, выделенный полипептид и способ его получения, способ обнаружения их присутствия в образце (варианты), клетка-хозяин (варианты), антитело, набор (варианты), способ модулирования активности полипептида, способ идентификации (варианты) и применение соединения, способ выявления субъекта (варианты) и способ лечения субъекта с нарушением, связанным с калиевыми каналами (варианты) | |
DK1183355T3 (da) | T-BET-præparater og fremgangsmåder til fremstilling heraf | |
WO2000012544A3 (en) | Novel irap-bp polypeptide and nucleic acid molecules and uses therefor | |
EA200100566A1 (ru) | Выделенная молекула нуклеиновой кислоты, выделенный полипептид и способ его получения, способ обнаружения их присутствия в образце (варианты), клетка-хозяин (варианты), антитело, набор (варианты), способ модулирования активности полипептида, способ идентификации (варианты) и применение соединения, способ выявления субъекта (варианты) и способ лечения субъекта с нарушением, связанным с калиевыми каналами (варианты) | |
ATE433489T1 (de) | 16836, ein mitglied der humanen phospholipase c familie und seine verwendungen | |
NO20012471L (no) | Kaliumkanal-interaktorer og anvendelser derav | |
WO2002044358A3 (en) | Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3 | |
WO2001083523A3 (en) | Stmst protein and nucleic acid molecules and uses therefor | |
DK1328621T3 (da) | 13245, en ny human proteinkinase af den myotoniske dystrofitype og anvendelser deraf | |
WO2002070708A3 (en) | Glutamate receptor modulatory proteins and nucleic acids encoding them | |
WO1999067387A3 (en) | Novel mp-7 protein and nucleic acid molecules and uses therefor | |
WO2002040655A3 (en) | Phospholipase a2 group preferentially expressed in th2 cells | |
WO2002012282A3 (en) | Novel ebi-3-alt protein and nucleic acid molecules and uses therefor |